Prior Auth Required

0537T - for development of genetically modified autologous CAR-T cells, per day

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Servicefor development of genetically modified autologous CAR-T cells, per day
Procedure / Service Description

Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes - 0532T interpretation; implantable monitor only Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes 0537T for development of genetically modified autologous CAR-T cells, per day Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes 0538T for transportation (eg, cryopreservation, storage)

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.